|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.605 USD | -0.32% |
|
+4.05% | -14.76% |
Sagimet Biosciences Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 2 million. Net loss was USD 27.88 million compared to USD 30.5 million a year ago.
Basic loss per share from continuing operations was USD 2.66 compared to USD 165.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.76% | 147M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
SAGIMET BIOSCIENCES INC. 
